Calumet (CLMT) EBIT (2023 - 2026)

Calumet (CLMT) has 4 years of EBIT data on file, last reported at -$171.3 million in Q1 2026.

• On a quarterly basis, EBIT fell 251.75% year-over-year to -$171.3 million in Q1 2026; TTM through Mar 2026 was -$13.9 million, a 81.92% increase from a year earlier, with the FY2025 full-year figure at $108.7 million, up 1241.98% from the prior year.
• EBIT for Q1 2026 stood at -$171.3 million, down from -$64.5 million in the prior quarter.
• Over the last five years, EBIT for CLMT reached as high as $322.9 million in Q3 2025 and fell as low as -$171.3 million in Q1 2026.
• Historically, EBIT has averaged $14.1 million across 4 years, with a median of -$3.8 million in 2023.
• On a YoY basis, EBIT climbed as much as 665.5% in 2025 and fell as far as 1729.03% in 2025.
• Year by year, EBIT stood at -$13.9 million in 2023, then jumped by 263.31% to $22.7 million in 2024, then tumbled by 384.14% to -$64.5 million in 2025, then plunged by 165.58% to -$171.3 million in 2026.
• Per Business Quant data, the three most recent EBIT figures were -$171.3 million in Q1 2026, -$64.5 million in Q4 2025, and $322.9 million in Q3 2025.